Literature DB >> 25945606

Urine matrix metalloproteinases and their extracellular inducer EMMPRIN in children with chronic kidney disease.

Kinga Musiał1, Agnieszka Bargenda1, Danuta Zwolińska1.   

Abstract

BACKGROUND: Transforming growth factor (TGF)beta1 and matrix metalloproteinases (MMPs) play an essential role in CKD-related tissue remodeling. However, there are no data on urine MMPs and their extracellular inducer EMMPRIN in CKD patients. The aim of study was to assess the concentrations of MMP-2, MMP-7, MMP-9, EMMPRIN and TGFbeta1 in serum and urine of CKD children and to analyze the potential relations between those parameters.
METHODS: Forty-one pre-dialysis CKD children and 23 age-matched controls were enrolled in the study. The concentrations of analyzed parameters were assessed by ELISA.
RESULTS: Serum and urine values of MMP-2, MMP-7, MMP-9, EMMPRIN and TGFbeta1 were significantly elevated in CKD patients versus controls. The MMP-2 and MMP-9 levels in urine correlated significantly with the corresponding values in serum, whereas MMP-7, EMMPRIN and TGFbeta1 urine concentrations did not. There were also significant correlations between urine values of all parameters.
CONCLUSIONS: The increased urine levels of MMPs, EMMPRIN and TGFbeta1 indicate enhanced proteolysis and renal tissue remodeling. In the case of MMP-7, EMMPRIN and TGFbeta1 those disturbances seem independent of enhanced serum activity of the corresponding enzymes. The urine MMP-7 and EMMPRIN concentrations may serve as new independent indices of tissue remodeling and renal interstitial fibrosis in children with CKD.

Entities:  

Keywords:  EMMPRIN; MMP-2; MMP-7; MMP-9; TGFbeta1

Mesh:

Substances:

Year:  2015        PMID: 25945606     DOI: 10.3109/0886022X.2015.1040715

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  4 in total

1.  Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy.

Authors:  Magdalena Krochmal; Georgia Kontostathi; Pedro Magalhães; Manousos Makridakis; Julie Klein; Holger Husi; Johannes Leierer; Gert Mayer; Jean-Loup Bascands; Colette Denis; Jerome Zoidakis; Petra Zürbig; Christian Delles; Joost P Schanstra; Harald Mischak; Antonia Vlahou
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

Review 2.  The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases.

Authors:  Zhao Liu; Roderick J Tan; Youhua Liu
Journal:  Biomolecules       Date:  2020-06-25

Review 3.  Role of Cachexia and Fragility in the Patient Candidate for Cardiac Surgery.

Authors:  Calogera Pisano; Daniele Polisano; Carmela Rita Balistreri; Claudia Altieri; Paolo Nardi; Fabio Bertoldo; Daniele Trombetti; Laura Asta; Maria Sabrina Ferrante; Dario Buioni; Calogero Foti; Giovanni Ruvolo
Journal:  Nutrients       Date:  2021-02-05       Impact factor: 5.717

Review 4.  Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease.

Authors:  Zhonghong Yan; Guanran Wang; Xingyang Shi
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.